This diabetes breakthrough drug slashes risk by 94%—discover how tirzepatide is transforming obesity treatment
Eli Lilly and Company (NYSE: LLY) has released compelling results from the SURMOUNT-1 study, which highlights that tirzepatide (branded as Zepbound and Mounjaro) dramatically cuts ... Read More
How Celery Can Transform Your Health: Medicinal Uses and More!
Celery, known scientifically as *Apium graveolens*, belongs to the Apiaceae or Umbelliferae family. This biennial herb has been revered for its medicinal properties and culinary ... Read More
Transform your body with these proven weight loss strategies!
Weight loss is a common challenge faced by people around the globe. Achieving and maintaining a healthy weight requires strong determination and a strategic approach. ... Read More
Apple Cider Vinegar: A Natural Aid for Weight Loss
Apple Cider Vinegar (ACV), a form of vinegar made from cider or apple must, has been gaining popularity as a weight loss aid. Characterized by ... Read More
Unlocking the wonders of Avocado: A comprehensive health guide
Avocados, with their creamy texture and rich flavor, have transcended the realm of culinary delights to emerge as a powerhouse of nutrition. Grown in warm ... Read More
Unveiling the superfood powers of Quinoa: A comprehensive health guide
Quinoa, often lauded as a miraculous grain, has solidified its status as a staple in the health-conscious community. Not merely a trend among vegetarians and ... Read More
Lilly’s Zepbound marks remarkable weight loss milestone in SURMOUNT-4 study
In a significant development in the field of obesity treatment, Lilly's Zepbound (tirzepatide) has shown remarkable results in the SURMOUNT-4 study. Published in The Journal ... Read More
Lilly bags Zepbound FDA approval for obesity treatment
The U.S. Food and Drug Administration has granted approval to Eli Lilly's Zepbound (tirzepatide) injection, making it the only obesity treatment that activates both GIP ... Read More
Eli Lilly’s Tirzepatide triumphs in Phase 3 weight loss studies
Eli Lilly and Company has unveiled the results of two Phase 3 tirzepatide studies (SURMOUNT-3 and SURMOUNT-4) targeting adults with obesity or overweight with weight-related ... Read More
Sun Pharma’s GL0034 yields promising results in two Phase 1 trials
Sun Pharmaceutical Industries has unveiled positive results from two Phase 1 studies assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034, a novel long-acting GLP-1 ... Read More